The Maharashtra government on Thursday banned the sale of ‘Coronil’, the medicine launched by Baba Ramdev’s Patanjali Ayurveda, that claims to cure COVID-19. The state government has categorically stated that they will take action against Patanjali Ayurveda that makes ayurvedic medicines if they promote the anti-COVID drug.
Anil Deshmukh, Home Minister of the state said, “Maharashtra government will take legal action against Patanjali if they try to advertise or sell their anti-Corona drug as AYUSH Ministry is yet to approve the medicine.” Deshmukh further added that the Maharashtra government would not allow the sale of the drug in the state till it was cleared by the National Institute of Medical Sciences, Jaipur.
Maharashtra govt will take legal action against Patanjali if they try to advertise or sell their anti-Corona drug as AYUSH Ministry is yet to approve the medicine: Anil Deshmukh, Maharashtra Home Minister (File pic) pic.twitter.com/bYTHnYD0Q6
— ANI (@ANI) June 25, 2020
The claim by Patanjali came a day after the Uttarakhand government said that Patanjali had only applied for a license to manufacture an immunity booster against cough and fever, then how can it launch a drug which claims to treat COVID-19.
Patanjali launched the Ayurvedic medicine ‘Coronil and Swasari’ on Tuesday claiming that it has shown 100 percent favourable results during clinical trials and can treat COVID-19 patients in just seven days. However, the Ministry of Ayush has asked the ayurvedic company to give a detailed report on composition, testing, and other data of the drugs used.
Also Read: Trump Signs Order To Suspend H1b1 Visas
Ministry of Ayush has also asked the ayurvedic company to stop publicising and advertising the claims of Coronil, corona cure drug, until the medicine is fully examined. YS Rawat, Uttarakhand’s Ayurveda department’s license officer said, “Notice has been issued to the firm to explain the grounds on which it got the permission to launch a “corona kit” as a cure for the virus.”
It is reported that a notice will be sent to the firm under Rule 170 of the Drugs and Cosmetics Act, 1940, according to which it is mandatory for a company to seek permission from the licensing authority before advertising a product in print or on electronic media.
Meanwhile, the Rajasthan government has also said that the drug cannot be not used as a medicine in the state without the permission of the Ministry of AYUSH. The government stressed that the state won’t permit the sale of the drug without approval from the Indian Council of Medical Research (ICMR).
https://twitter.com/ANI/status/1276058069307232256 моментальный займ на карту сбербанкасрочный займ 100000срочный займ на карту сбербанка маэстро займ домохозяйкамполучить займ с плохой кибыстрый займ новороссийск